FDA approves Leqembi Iqlik® (lecanemab-irmb) subcutaneous injection as a starting dose for early Alzheimer's disease

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 9/14/2026

1. ORCL
2. NVDA
3. USO
4. SPY
5. SRRK
6. DFTX
7. AZN
8. CGEM
9. LYNX
10. SATL

Go back to FDA approves Leqembi Iqlik® (lecanemab-irmb) subcutaneous injection as a starting dose for early Alzheimer's disease
BARNES GROUP, Inc. (NYSE: B) Delayed: 42.73 -0.95 (2.17%)
Previous Close $43.68    52 Week High $44.27 
Open $42.47    52 Week Low $30.07 
Day High $42.83    P/E 32.62 
Day Low $41.88    EPS $1.31 
Volume 4,399,005       

BIOAMBER, Inc. (NASDAQ: BIOA) Delayed: 8.52 +0.03 (0.35%)
Previous Close $8.49    52 Week High $8.73 
Open $8.52    52 Week Low $2.86 
Day High $8.64    P/E N/A 
Day Low $8.39    EPS $-3.82 
Volume 201,837